Preview

Complex Issues of Cardiovascular Diseases

Advanced search

Submissions

Online Submissions

Already have a Username/Password for Complex Issues of Cardiovascular Diseases?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

Start submission
 

Author Guidelines

Editorial Office of the international, peer-reviewed journal “Complex Issues of Cardiovascular Diseases” encourages all authors to read the following instructions for preparing manuscripts for submission.

Manuscripts must conform to Complex Issues of Cardiovascular Diseases Instructions for Authors based on the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/recommendations/).

The editors require authors to comply with the above regulations, otherwise publication could be denied. Articles are accepted through the online submission system (http://journal.kemcardio.ru/jour/login?source=%2Fjour%2Fauthor%2Fsubmit%2F1).

General format

Prepare the manuscript text using a Word processing package (save in .doc format). Submission of PDF text files is not permitted. Manuscripts should be written in 12 size with a 1.5 line style, including text, tables, legends, and references. Each page should be consecutively numbered. An original article should contain no more than 20 A4 pages (including tables and references), a clinical case – 4 to 5 pages, an overview and a meta-analysis – 25 pages.

 

Title Page. The title page should contain 1) the title; 2) first name, middle initial, and last name of each author; (3) the institution(s) where the work was performed, (4) the position, institution, and location of all authors, (5) the telephone number, fax number, and e-mail address of the corresponding author, (6) the institutional affiliations of the authors (including corporate appointments) should be acknowledged in a footnote.

 

Abstract. Structured abstracts are required for all manuscripts (except editorials, letters to the editor). All abstracts must be restricted in length to 250-300 words.  submitted to Complex Issues of Cardiovascular Diseases. The abstract should be formatted with the following headings: (1) Aims, (2) Methods, (3) Results, (4) Conclusion, (5) Keywords. The authors should also provide no more than 10 keywords for indexing.

 

Conflict of Interest. Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional, and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated in Conflict of Interest section as “none declared”.

 

Funding. Details of all funding sources for the work in question should be given in a separate section entitled “Funding”. This should appear before the “Acknowledgements” section.

 

The following rules should be followed:

a) The sentence should begin: ‘This work was supported by …’

b) The full official funding agency name should be given, i.e. ‘the National Cancer Institute at the National Institutes of Health’ or simply 'National Institutes of Health' not ‘NCI' (one of the 27 sub-institutions) or 'NCI at NIH’ (full RIN-approved list of UK funding agencies)

c) Grant numbers should be complete and accurate and provided in brackets as follows: ‘[grant number ABX CDXXXXXX]’

d) Multiple grant numbers should be separated by a comma as follows: ‘[grant numbers ABX CDXXXXXX, EFX GHXXXXXX]’

e) Agencies should be separated by a semi-colon (plus ‘and’ before the last funding agency)

f) Where individuals must be specified for certain sources of funding, the following text should be added after the relevant agency or grant number 'to [author initials]'.

 

An example is given here: ‘This work was supported by the National Institutes of Health [P50 CA098252 and CA118790 to R.B.S.R.] and the Alcohol & Education Research Council [HFY GR667789].

 

Acknowledgements. Substantive contributions of individuals should be noted in an Acknowledgements section and entered before the Conflict of Interest statement.

 

Abbreviations

Abbreviations should be minimized and avoided wherever possible. The full term for which an abbreviation stands should be used at its first occurrence in the text unless it is a standard unit of measure. The abbreviation should appear in parentheses after the full term. Abbreviations should not be in the title, figure legends, or table titles.

 

Tables

Tables are included in the manuscript text. Tables should not duplicate the text. Data given in tables must conform to those in the text. Each table should be numbered in sequence using Arabic numerals (e.g. Table 1.). Tables should also have a title above and an explanatory footnote below.

 

Figures

Figures must not duplicate data given in Tables or in the text. They must be suitable for high quality reproduction and should be submitted in the desired final printed size so that reduction can be avoided. Figures are included in the main manuscript and should be numbered in sequence using Arabic numerals (e.g. Fig. 1. ). Figures should also have a title and a legend below. Figure legends should contain enough information for the reader to understand the figure without referring to the text.

 

Units of Measure

Authors should provide units of measurement in SI units.

 

References

References should be identified in the text by Arabic numerals and numbered in the order cited. All references should be compiled at the end of the article in the recommended style for references based on the National Information Standards Organization NISO Z39.29-2005 (R2010) Bibliographic References as adapted by the National Library of Medicine for its databases. (https://www.nlm.nih.gov/bsd/uniform_requirements.html). Details, including fuller citations and explanations, are in Citing Medicine (https://www.ncbi.nlm.nih.gov/books/NBK7256/).

Complete information should be given for each reference, including the title of the article, abbreviated journal title, and page numbers. All authors should be listed, i.e. “et al” should not be used.

 

1. Article citation example:

Schroeder S, Baumbach A, Mahrholdt H. The impact of untreated coronary dissections on the acute and long-term outcome after intravascular ultrasound guided PTCA. Eur Heart J 2000;21:137-145.

 

2. Book citation example:

Nichols WW, Rourke MF. Aging, High Blood Pressure and Disease in Human. 3rd ed. London/Melbourne: Lea and Febiger; 1990.

 

3. Chapter citation example:

Nichols WW, O'Rourke MF. Aging, high blood pressure and disease in humans. In: Arnold E, ed. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 3rd ed. London/Melbourne/Auckland: Lea and Febiger; 1990. p398-420.

 

4. Webpage citation example:

Panteghini M. Recommendations on use of biochemical markers in acute coronary syndrome: IFCC proposals. eJIFCC 14. http://www.ifcc.org/ejifcc/vol14no2/1402062003014n.htm (28 May 2004)

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The manuscripts are accepted if has not been published or submitted for publication elsewhere.
  2. The manuscript is an original work free from plagiarism and does not duplicate previous manuscripts of the authors.

  3. All the studies and researchers cited in the manuscript have references to the primary sources and are included in  References section.

  4. Conflict of interests section and Funding section are included in the main manuscript text.
  5. The submitted manuscript adheres all ethical guidelines. 

  6. The manuscript has been read and approved by all named authors. There are no other persons who satisfied the criteria for authorship but are not listed. The order of authors listed in the manuscript has been approved by all authors.

  7. Information about the authors and their affiliations are relevant. The corresponding author provided his or her phone number and e-mail.
  8. The manuscripts adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

  9. All supplementary documents have been prepared and upload.

  10. Submissions that do not adhere to these guidelines may be returned to the author(s). 

 

Copyright Notice

Authors who publish with this journal agree to the following terms:

 

  • Authors retain copyright and grant Complex Issues of Cardiovascular Diseases right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in Complex Issues of Cardiovascular Diseases.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Complex Issues of Cardiovascular Diseases.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

 

Privacy Statement

Any manuscripts received for review by Complex Issues of Cardiovascular Diseases are considered as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.